About Us
A Clearer Path to Wellness
Clear Path Clinical Research is a boutique, independent clinic founded in 2024 by Dr. Molly Davis. At Clear Path Psychiatry, we are dedicated to advancing psychiatric care by bringing innovative interventions to the forefront of medicine, especially for those facing chronic psychiatric conditions.
Our Story
​At Clear Path Clinical Research, we are dedicated to staying at the forefront of psychedelic medicine. Clear Path Clinical Research was founded by Dr. Molly Davis, M.D., a dual board certified interventional psychiatrist who is trained through MAPS (the Multidisciplinary Association for Psychedelic Studies) to deliver MDMA-assisted therapy for PTSD pending FDA approval; Dr. Davis completed a yearlong fellowship in psychedelic medicine through the Integrative Psychiatry Institute and is passionate about staying up to date with the evidence for psychedelic medicine to treat mental illnesses.
Currently, there are no FDA-approved psychedelic medicines for any medical condition, and we offer these treatments solely within the context of carefully controlled clinical trials. The medication Spravato, intranasal esketamine, has some psychedelic properties and is FDA-approved for treatment resistant depression. Ketamine and esketamine are dissociative anesthetics with psychedelic properties, however, and not considered to be classic psychedelics. Our research investigates how classic psychedelic compounds might help address a range of challenging conditions, including postpartum depression, end-of-life anxiety and existential despair, difficult-to-treat depression, obsessive-compulsive disorder, substance use disorders, addictions, and post-traumatic stress disorder (PTSD).
​
The potential mechanisms of action for psychedelics are intriguing and complex. One key area of study involves the impact of psychedelics on the brain’s default mode network (DMN)—a neural network linked to self-referential thinking, rumination, and a rigid sense of self. By reducing the dominance of the DMN, psychedelics may allow individuals to break free from cycles of repetitive, negative thought patterns and rigid self-narratives, leading to new insights and emotional breakthroughs. Additionally, research has shown that psychedelics may reopen critical periods of heightened meta-plasticity in the brain, allowing for new learning.​
Meet The Doctor
Molly Davis, MD
I graduated with distinction from Stanford University, earning a B.S. in Human Biology. I received my M.D. from the University of Washington School of Medicine in 2001 and completed a general psychiatry residency and geriatric psychiatry fellowship at Oregon Health & Science University (OHSU), where I served as chief resident in my final year. I am board-certified in both general and geriatric psychiatry. After my training, I joined the OHSU faculty as a geriatric psychiatrist. My specialties include treating refractory mood disorders with electroconvulsive therapy (ECT), evaluating and treating major neurocognitive disorders (dementia), and diagnosis and treatment of movement disorders. I have additional training in neurology and movement disorders. I have worked in various inpatient and outpatient psychiatric settings. In 2018, I immersed myself in studying psychedelic medicine. I am trained through the Multidisciplinary Association for Psychedelic Studies (MAPS) to offer MDMA-assisted therapy for individuals with treatment-resistant PTSD pending FDA approval. I completed a year-long fellowship through the Integrative Psychiatry Institute in psychedelic-assisted therapy and am eager to offer psychedelic medicines as they gain FDA approval. Beyond my professional pursuits, my personal journey has equipped me with a unique perspective on navigating life as a patient. Having undergone treatment for triple-negative breast cancer in 2018, followed by acute myeloid leukemia and a stem-cell (bone marrow) transplant in 2020, I have a deep understanding of the challenges faced by individuals with life-threatening illnesses and those confronting mortality. I know the frustrations of navigating the medical system and trying to be an advocate for yourself while you are sick. I am passionate about working with people who live with life-threatening and chronic illnesses. I believe that psychedelic-assisted therapy, in particular, can help individuals find meaning, hope, and joy in their lives, even when facing grief, loss, chronic illness or mortality.